Browse news and resources by disease area

Browse malaria and vaccination recommendations by country

Additional bipolar indication for Seroquel

on the 29 October 2009

Seroquel and Seroquel XL (quetiapine) have been approved for the treatment of major depressive episodes in adults with bipolar disorder, in addition to the products' existing indications for schizophrenia and manic episodes. The new indication, for which the maximum daily dose is 600mg, carries a black triangle to indicate that all adverse events should be reported.